← Back
$INO All transactions

INOVIO PHARMACEUTICALS, INC.

F

$ Value

$15K

Shares

7,717

Price

$2

Filed

May 16

Insider

Name

Shea Jacqueline Elizabeth

Title

Chief Executive Officer

CIK

0001771498

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-15

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

59,685

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. | The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.

Filing Info

Accession No.

0001055726-25-000030

Form Type

4

Issuer CIK

0001055726

Shea Jacqueline Elizabeth's History

Date Ticker Type Value
2025-05-20 INO A $0
2025-05-20 INO A $0
2025-05-15 INO M
2025-05-15 INO F $15K
2025-05-15 INO M $0
2025-05-10 INO M
2025-05-10 INO F $4K
2025-05-10 INO M $0

Other Insiders at INO (90d)

Insider Bought Sold Last
Sumner Michael John
Chief Medical Officer
2026-03-31